German Pharmacists View VAT Cut, OTCs

23 October 1997

At their annual conference, Germany's pharmacists have urged thegovernment to cut value-added tax from 15% to 7%, saying this would relieve the health funds of a 2.3 billion Deutschemarks ($1.29 billion) cost burden and ease their financial crisis. The pharmacists said the full rate of VAT is not applied in almost all other comparable European Union member states, and only in Denmark is a higher rate of VAT applied to drugs than in Germany.

They also agreed on a plan to expand self-medication with a higher level of advice from pharmacies, by restricting nonprescription items such as health teas and garlic preparations to pharmacies, and thus excluding them from drugstores, supermarkets and similar outlets.

The pharmacists say they account for only about 700 million marks of nonprescription products' 2 billion marks annual sales, the rest going to superstores and chains. Self-medication sales account for 18% of pharmacy sales and are rising. German pharmacy sales rose 4.5% to 45 billion marks in 1996.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight